Frazier Life Sciences Management’s Attovia Therapeutics ATTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$121M Buy
+7,046,271
New +$148M 3% 10

Other funds holding ATTO

Frazier Life Sciences Management's ATTO Position: Q3 2026 in Review

Frazier Life Sciences Management opened a new position in Attovia Therapeutics (ATTO) in Q3 2026: 7,046,271 shares worth $121M. The stake represents 3% of the portfolio and ranks #10 among its holdings.

57 funds tracked by Wall St. Rank hold ATTO as of Q3 2026.

  • Frazier Life Sciences Management held 7,046,271 shares of Attovia Therapeutics worth $121M as of Q3 2026.
  • Attovia Therapeutics was a new Frazier Life Sciences Management position in Q3 2026.
  • Attovia Therapeutics made up 3% of Frazier Life Sciences Management's portfolio in Q3 2026, its #10 holding.
  • 57 funds tracked by Wall St. Rank held Attovia Therapeutics as of Q3 2026.

Based on Frazier Life Sciences Management's 13F filing for Q3 2026, filed 16 Nov 2026.